Federal contract

Harvard Bioscience (HBIO): DoD awarded $23K

DoD awarded Harvard Bioscience a contract with $23K committed so far.

$23K
committed so far
Signed
Dec 15, 2025
Updated
Mar 2, 2026

What stands out in this filing

  • #9 of 10 awards mapped to this company, by money obligated.
  • One agency accounts for 72.6% of the awards mapped to this company over the last 12 months.

Calculated by OQRO from this filing and the public records it holds. Facts about the record, not a reason for the trade and not a signal.

The story around this disclosure

Every dated public record OQRO holds about the company from 60 days before to 120 days after, oldest first. It shows what was going on; none of it is a stated reason for the trade.

  1. Nov 6, 2025Company filing · Form 8-K · ResultsReported its results
  2. Dec 12, 2025Federal contract · $258K obligatedDepartment of Defense awarded HARVARD BIOSCIENCE INC: $258K obligated to date
  3. Dec 15, 2025 · this disclosureFederal contract · $23K obligatedDepartment of Defense awarded HARVARD BIOSCIENCE INC: $23K obligated to date

What came next

  1. Dec 17, 2025Company filing · Form 8-K · Material agreement, Agreement endedChanged a top executive or board member, and signed an important agreement (and 2 more items)“of Certain Officers As noted in Item 1.01 above, the Board has appointed Mr. William A. Snider as a member of the Board and the Compensation Committee of the Board, effective December 17, 2025.”
  2. Jan 8, 2026Federal contract · $127K obligatedDepartment of Veterans Affairs awarded HARVARD BIOSCIENCE INC: $127K obligated to date
  3. Jan 14, 2026Federal contract · $22K obligatedDepartment of Defense awarded HARVARD BIOSCIENCE INC: $22K obligated to date
  4. Jan 19, 2026Company filing · Form 8-K · Bylaws or charterChanged its bylaws, charter or fiscal year
  5. Jan 23, 2026Company filing · Form 8-K · Restructuring, Reg FDAnnounced job cuts, closures or a restructuring, and shared information with investors“On January 23, 2026, the Board of Directors of Harvard Bioscience, Inc. (the “Company”) approved management’s comprehensive plan, referred to as Project Viking, for the strategic consolidation of its manufacturing operations to improve efficiency and support long-term growth.”
  6. Feb 10, 2026Company filing · Form 8-K · ResultsReported its results
  7. Mar 6, 2026Company filing · Form 8-K · Executive changeChanged a top executive or board member“On March 6, 2026, Harvard Bioscience, Inc. (the “Company”) entered into an Amended and Restated Employment Agreement (the “Duke Employment Agreement”) with John Duke, the Company’s Chief Executive Officer.”
  8. Mar 12, 2026Company filing · Form 8-K · ResultsReported its results
  9. Mar 16, 2026Insider · 3 peopleInsiders: 3 purchases (~$113K)
  10. Mar 17, 2026Insider · 2 peopleInsiders: 2 purchases (~$90K)
View the official recordUSAspending.gov award record

How to read USAspending.gov award record

The obligated amount is money the government has legally committed to pay and has set aside in its accounts. The ceiling, which USAspending calls the potential value, is the most the contract could be worth if every option is exercised and every possible order is placed. The ceiling is a limit, not a payment, and it is often many times the obligated amount.

Full guide: Contract ceiling vs obligated amount: the difference

What else is on file for Harvard Bioscience

For Harvard Bioscience, OQRO holds 2 federal contract awards dated in the last 90 days.

These are records OQRO holds, counted by their date, not a measure of how much trading took place. Routine paperwork such as option exercises and tax withholding is left out. Everything for the company is on its HBIO page.

How this filing works

Explore the data

Common questions

What federal contract did Harvard Bioscience (HBIO) receive?

DoD awarded Harvard Bioscience a contract with $23K committed so far. Defense Health Agency.

When did it happen, and when was it made public?

Signed: Dec 15, 2025. Updated: Mar 2, 2026.

What stands out in this filing?

#9 of 10 awards mapped to this company, by money obligated. One agency accounts for 72.6% of the awards mapped to this company over the last 12 months.

Is the contract value money the company has received?

No. The award record gives the amount committed so far and a ceiling the contract may reach. Neither is revenue: the company is paid as the work is delivered, and a contract can be cut short.

Where does this information come from?

From the USAspending.gov award record, a public record. The link to the official record is on this page, and OQRO copies its figures without changing them.

What else has been disclosed about Harvard Bioscience recently?

For Harvard Bioscience, OQRO holds 2 federal contract awards dated in the last 90 days. They are listed on the HBIO page.

Does this mean HBIO stock is a buy or a sell?

No. This page describes one public filing. A filing does not say why someone traded and is not a forecast, so OQRO gives no recommendation.

Is OQRO free?

Yes. Every page of OQRO is free with an account, which takes a minute with Google and needs no card. Only the AI assistant is paid.

Other disclosures at Harvard Bioscience

Everything OQRO holds on this company is on its HBIO page.

This is one filing. OQRO holds the rest

Insider trades filed with the SEC, stock trades disclosed by members of Congress, fund holdings from 13F filings and federal contract awards, each one in plain words next to its official filing. On this page it opens why the trade stands out, what the company did around that time, the price since, and every field of the form.

OQRO is free for everyone. No card, no trial

OQRO describes public disclosures and context calculated from them. It does not give personalized advice and does not recommend any transaction. How OQRO treats data